Eisai to Present New Lecanemab Data at AD/PD 2026...
Category : Product Related Updates 11 March 2026Eisai Co., Ltd. will present new research on Lecanemab, its therapy for Alzheimer's disease, at...
Eisai Co., Ltd. will present new research on Lecanemab, its therapy for Alzheimer's disease, at...
Altamira Therapeutics announced that its associate company, Altamira Medica, has received a notice o...
New real-world research presented at the AAAAI Annual Meeting suggests that glucagon-like peptide-1...
NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...
AskBio Inc., a gene therapy company wholly owned by Bayer AG, has received US FDA acceptance for its...